Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome

Conditions:   Obstructive Sleep Apnea;   Down Syndrome Intervention:   Drug: Atomoxetine and Oxybutynin (ato-oxy) Sponsors:   University of Arizona;   National Institutes of Health (NIH);   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials